T Cells Contribute to Stroke-Induced Lymphopenia in Rats

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Gu, Lijuan ^a,b   Xiong, Xiaoxing ^b   Wei, Dingtai ^b   Gao, Xuwen ^b   Krams, Sheri ^b   Zhao, Heng ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CONCANAVALIN A; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MACROPHAGE ACTIVATION; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SPECIES DIFFERENCE; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE;

ANIMALS; BRAIN INFARCTION; BREEDING; CELL PROLIFERATION; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; LYMPHOPENIA; MACROPHAGES; MALE; RATS; SPECIES SPECIFICITY; SPLEEN; STROKE; T-LYMPHOCYTES; TRANSPLANTS;

EID: 84875024484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059602     Document Type: Article

References (52)

1. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U, (2005) Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6: 775-786.
2. Iadecola C, Anrather J, (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808.
3. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, et al. (2012) The immunology of acute stroke. Nat Rev Neurol 8: 401-410.
4. Prass K, Meisel C, Hoflich C, Braun J, Halle E, et al. (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198: 725-736.
5. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, et al. (2006) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176: 6523-6531.
6. Brown M, Glassenberg M, (1973) Mortality factors in patients with acute stroke. JAMA 224: 1493-1495.
7. Czlonkowska A, Cyrta B, Korlak J, (1979) Immunological observations on patients with acute cerebral vascular disease. J Neurol Sci 43: 455-464.
8. Kostic V, Mostarica-Stojkovic M, Ramic Z, Kovacevic M, Lukic M, (1988) Serum immunoinhibitory factors in stroke patients. Eur Neurol 28: 331-334.
9. Kurabayashi H, Kubota K, Machida I, Tamura K, Take H, et al. (1996) Effects of physical therapy on immunological parameters in patients with cerebrovascular diseases. J Med 27: 171-175.
10. Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, et al. (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39: 237-241.
11. Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, et al. (2009) Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 40: 3226-3232.
12. Urra X, Cervera A, Villamor N, Planas AM, Chamorro A, (2009) Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158: 1174-1183.
13. Offner H, Vandenbark AA, Hurn PD, (2009) Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 158: 1098-1111.
14. Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, et al. (2008) Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 25: 50-58.
15. Meisel C, Prass K, Braun J, Victorov I, Wolf T, et al. (2004) Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35: 2-6.
16. Sarrafzadeh A, Schlenk F, Meisel A, Dreier J, Vajkoczy P,et al. Immunodepression after aneurysmal subarachnoid hemorrhage. Stroke 42: 53-58.
17. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P, (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334: 101-105.
18. Tarkowski E, Ekelund P, Tarkowski A, (1991) Increased systemic T-lymphocyte reactivity in patients with established stroke. J Clin Lab Immunol 35: 171-176.
19. Schulte-Herbruggen O, Quarcoo D, Meisel A, Meisel C, (2009) Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation 16: 213-218.
20. Lommatzsch M, Schloetcke K, Klotz J, Schuhbaeck K, Zingler D, et al. (2005) Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am J Respir Crit Care Med 171: 115-120.
21. Peterfalvi A, Molnar T, Banati M, Pusch G, Miko E, et al. (2009) Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Cerebrovasc Dis 28: 490-498.
22. Vogelgesang A, May VE, Grunwald U, Bakkeboe M, Langner S, et al. (2010) Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 5: e8718.
23. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, et al. (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 28: 12023-12031.
24. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, et al. (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 26: 6413-6421.
25. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, et al. (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28: 927-938.
26. Wild CA, Bergmann C, Fritz G, Schuler P, Hoffmann TK, et al. (2012) HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. Int Immunol 24: 485-494.
27. Sakamoto R, Okano M, Takena H, Ohtsuki K, (2001) Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol Pharm Bull 24: 906-911.
28. Hirasawa T, Yamashita H, Makino S, (1998) Genetic typing of the mouse and rat nude mutations by PCR and restriction enzyme analysis. Exp Anim 47: 63-67.
29. Zhao H, Sapolsky RM, Steinberg GK, (2006) Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 26: 1114-1121.
30. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, et al. (2005) Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25: 9794-9806.
31. Gu L, Xiong X, Zhang H, Xu B, Steinberg GK, et al. (2012) Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke 43: 1941-1946.
32. Lim JK, Obara CJ, Rivollier A, Pletnev AG, Kelsall BL, et al. (2011) Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol 186: 471-478.
33. Ajmo CT Jr, Vernon DO, Collier L, Hall AA, Garbuzova-Davis S, et al. (2008) The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 86: 2227-2234.
34. Wei D, Ren C, Chen X, Zhao H, (2012) The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One 7: e30892.
35. Gao X, Zhang H, Steinberg G, Zhao H, (2010) The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in Rats. Transl Stroke Res 1: 202-209.
36. Milicevic NM, Luettig B, Trautwein C, Wustefeld T, Mahler M, et al. (2001) Splenectomy of rats selectively reduces lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1 expression on B-cell subsets in blood and lymph nodes. Blood 98: 3035-3041.
37. Juneja S, Januszewicz E, Wolf M, Cooper I, (1995) Post-splenectomy lymphocytosis. Clin Lab Haematol 17: 335-337.
38. Emsley HC, Hopkins SJ, (2010) Post-stroke immunodepression and infection: an emerging concept. Infect Disord Drug Targets 10: 91-97.
39. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, et al. (2009) The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40: 2849-2858.
40. Klehmet J, Harms H, Richter M, Prass K, Volk HD, et al. (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158: 1184-1193.
41. Hedrick SM, (2002) T cell development: bottoms-up. Immunity 16: 619-622.
42. Stockinger B, Bourgeois C, Kassiotis G, (2006) CD4+ memory T cells: functional differentiation and homeostasis. Immunol Rev 211: 39-48.
43. King C, Tangye SG, Mackay CR, (2008) T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol 26: 741-766.
44. Inatsu A, Kogiso M, Jeschke MG, Asai A, Kobayashi M, et al. (2011) Lack of th17 cell generation in patients with severe burn injuries. J Immunol 187: 2155-2161.
45. Lee MKt, Moore DJ, Chiaccio M, Lian MM, Deng S, et al. (2006) T-reg mediated suppression of the allograft response in the draining lymph node. Transplantation 81: 1063-1066.
46. van Santen HM, Benoist C, Mathis D, (2004) Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 200: 1221-1230.
47. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, et al. (2009) In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 206: 751-760.
48. Theodorou GL, Marousi S, Ellul J, Mougiou A, Theodori E, et al. (2008) T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke. Clin Exp Immunol 152: 456-463.
49. Huang LF, Yao YM, Zhang LT, Dong N, Yu Y, et al. (2009) The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. Shock 31: 322-329.
50. Zhu XM, Yao YM, Liang HP, Xu CT, Dong N, et al. (2011) High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4. Cytokine 54: 296-304.
51. Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, et al. (2007) The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220: 47-59.
52. Yan J, Greer JM, Etherington K, Cadigan GP, Cavanagh H, et al. (2009) Immune activation in the peripheral blood of patients with acute ischemic stroke. J Neuroimmunol 206: 112-117.